grepcent public filings, reorganized for comparison

ACRS profile · all as-reported value updates

Aclaris Therapeutics, Inc. (ACRS) as-reported value updates

Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.

Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.

Rows publish only when the later filed value differs by at least 1.0% and at least $1,000,000, after dropping differences that match under the capped trailing-zero precision rule. The delta percent is delta divided by the larger absolute filed value. Values are annual standardized facts only; metrics whose differences fall below those thresholds or match the capped precision rule are not published as rows.

Ledger table figure

ACRS as-reported XBRL value updates. Compact figure; full filing links are in the page table.ACRS as-reported XBRL value updates. Compact figure; full filing links are in the page table.MetricFYThenNowDeltaDelta %Revenue2018$10.1M$6.2M-$3.9M-39.04%Operating income2018-$135.4M-$84.8M$50.6M+37.39%Operating income2017-$72.4M-$54.4M$18.1M+24.94%
MetricFYEarliest XBRL-filed valueCurrently on fileDifferenceDifference %LabelFiling linksNotes
Revenue
RevenueFromContractWithCustomerExcludingAssessedTax
201810,091,000
filed 2019-03-18 · 10-K
6,151,000
filed 2021-02-25 · 10-K
-3,940,000-39.04%revised comparative figure0001558370-19-002211
0001558370-21-001717
3 filed observations examined for this concept and period.
Operating income
OperatingIncomeLoss
2018-135,414,000
filed 2019-03-18 · 10-K
-84,780,000
filed 2021-02-25 · 10-K
50,634,000+37.39%revised comparative figure0001558370-19-002211
0001558370-21-001717
3 filed observations examined for this concept and period.
Operating income
OperatingIncomeLoss
2017-72,423,000
filed 2018-03-12 · 10-K
-54,361,000
filed 2020-02-25 · 10-K
18,062,000+24.94%revised comparative figure0001558370-18-001866
0001558370-20-001325
3 filed observations examined for this concept and period.